277 related articles for article (PubMed ID: 21308772)
21. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells.
Matsumoto Y; Otsuka F; Takano M; Mukai T; Yamanaka R; Takeda M; Miyoshi T; Inagaki K; Sada KE; Makino H
Mol Cell Endocrinol; 2010 Aug; 325(1-2):118-27. PubMed ID: 20638987
[TBL] [Abstract][Full Text] [Related]
22. Psoralidin, a prenylated coumestan, as a novel anti-osteoporosis candidate to enhance bone formation of osteoblasts and decrease bone resorption of osteoclasts.
Zhai Y; Li Y; Wang Y; Cui J; Feng K; Kong X; Chen L
Eur J Pharmacol; 2017 Apr; 801():62-71. PubMed ID: 28283388
[TBL] [Abstract][Full Text] [Related]
23. Positive regulation of osteogenesis by bile acid through FXR.
Cho SW; An JH; Park H; Yang JY; Choi HJ; Kim SW; Park YJ; Kim SY; Yim M; Baek WY; Kim JE; Shin CS
J Bone Miner Res; 2013 Oct; 28(10):2109-21. PubMed ID: 23609136
[TBL] [Abstract][Full Text] [Related]
24. Ethanol extract of Lithospermum erythrorhizon Sieb. et Zucc. promotes osteoblastogenesis through the regulation of Runx2 and Osterix.
Choi YH; Kim GS; Choi JH; Jin SW; Kim HG; Han Y; Lee DY; Choi SI; Kim SY; Ahn YS; Lee KY; Jeong HG
Int J Mol Med; 2016 Aug; 38(2):610-8. PubMed ID: 27353217
[TBL] [Abstract][Full Text] [Related]
25. Tunicamycin negatively regulates BMP2-induced osteoblast differentiation through CREBH expression in MC3T3E1 cells.
Jang WG; Kim EJ; Koh JT
BMB Rep; 2011 Nov; 44(11):735-40. PubMed ID: 22118540
[TBL] [Abstract][Full Text] [Related]
26. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells.
van der Horst G; Farih-Sips H; Löwik CW; Karperien M
J Bone Miner Res; 2005 Dec; 20(12):2233-44. PubMed ID: 16294276
[TBL] [Abstract][Full Text] [Related]
27. Combining bone morphogenetic proteins-2 and -6 has additive effects on osteoblastic differentiation in vitro and accelerates bone formation in vivo.
Visser R; Bodnarova K; Arrabal PM; Cifuentes M; Becerra J
J Biomed Mater Res A; 2016 Jan; 104(1):178-85. PubMed ID: 26238281
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous delivery of BMP-2 factor and anti-osteoporotic drugs using hyaluronan-assembled nanocomposite for synergistic regulation on the behaviors of osteoblasts and osteoclasts in vitro.
Zhang Y; Hu Y; Luo Z; Shen X; Mu C; Cai K
J Biomater Sci Polym Ed; 2015; 26(5):290-310. PubMed ID: 25585099
[TBL] [Abstract][Full Text] [Related]
30. Pyk2 deficiency potentiates osteoblast differentiation and mineralizing activity in response to estrogen or raloxifene.
Posritong S; Hong JM; Eleniste PP; McIntyre PW; Wu JL; Himes ER; Patel V; Kacena MA; Bruzzaniti A
Mol Cell Endocrinol; 2018 Oct; 474():35-47. PubMed ID: 29428397
[TBL] [Abstract][Full Text] [Related]
31. The Calcium-sensing Receptor (CaR) is involved in strontium ranelate-induced osteoblast differentiation and mineralization.
Takaoka S; Yamaguchi T; Yano S; Yamauchi M; Sugimoto T
Horm Metab Res; 2010 Aug; 42(9):627-31. PubMed ID: 20560105
[TBL] [Abstract][Full Text] [Related]
32. Notoginsenoside R1 significantly promotes in vitro osteoblastogenesis.
Liu Y; Lin Z; Guo J; Xu G; Li Y; Xu T; Lv H; Chen J; Wu G
Int J Mol Med; 2016 Aug; 38(2):537-44. PubMed ID: 27352906
[TBL] [Abstract][Full Text] [Related]
33. Epinephrine accelerates osteoblastic differentiation by enhancing bone morphogenetic protein signaling through a cAMP/protein kinase A signaling pathway.
Uemura T; Ohta Y; Nakao Y; Manaka T; Nakamura H; Takaoka K
Bone; 2010 Oct; 47(4):756-65. PubMed ID: 20637325
[TBL] [Abstract][Full Text] [Related]
34. JNK activity is essential for Atf4 expression and late-stage osteoblast differentiation.
Matsuguchi T; Chiba N; Bandow K; Kakimoto K; Masuda A; Ohnishi T
J Bone Miner Res; 2009 Mar; 24(3):398-410. PubMed ID: 19016586
[TBL] [Abstract][Full Text] [Related]
35. Thymoquinone accelerates osteoblast differentiation and activates bone morphogenetic protein-2 and ERK pathway.
Wirries A; Schubert AK; Zimmermann R; Jabari S; Ruchholtz S; El-Najjar N
Int Immunopharmacol; 2013 Feb; 15(2):381-6. PubMed ID: 23333454
[TBL] [Abstract][Full Text] [Related]
36. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK
J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186
[TBL] [Abstract][Full Text] [Related]
37. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis.
Dang ZC; van Bezooijen RL; Karperien M; Papapoulos SE; Löwik CW
J Bone Miner Res; 2002 Mar; 17(3):394-405. PubMed ID: 11878304
[TBL] [Abstract][Full Text] [Related]
38. The orphan nuclear receptor estrogen receptor-related receptor gamma negatively regulates BMP2-induced osteoblast differentiation and bone formation.
Jeong BC; Lee YS; Park YY; Bae IH; Kim DK; Koo SH; Choi HR; Kim SH; Franceschi RT; Koh JT; Choi HS
J Biol Chem; 2009 May; 284(21):14211-8. PubMed ID: 19324883
[TBL] [Abstract][Full Text] [Related]
39. Sanguis Draconis resin stimulates osteoblast alkaline phosphatase activity and mineralization in MC3T3-E1 cells.
Wang W; Olson D; Cheng B; Guo X; Wang K
J Ethnopharmacol; 2012 Jun; 142(1):168-74. PubMed ID: 22543168
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of heme oxygenase-1 inhibits the maturation and mineralization of osteoblasts.
Lin TH; Tang CH; Hung SY; Liu SH; Lin YM; Fu WM; Yang RS
J Cell Physiol; 2010 Mar; 222(3):757-68. PubMed ID: 20020468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
